Additionally, recent findings suggest that individuals with lipedema may present with altered vascular parameters, such as increased aortic stiffness, potentially associated with connective tissue changes secondary to hypermobility
Apr 07, 2026, 08:00 ET Wegovy HD available through 70,000+ US pharmacies, NovoCare Pharmacy, select telehealth providers, and more STEP UP trial data showed average weight loss of ~21% with Wegovy HD at 72 weeks in adults with obesity if all patients stayed on treatment * and ~19% regardless of whether patients stayed on treatment **1 Wegovy HD further expands the offerings for patients within the Wegovy label, inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., April 7, 2026 /PRNewswire/ -- Wegovy HD (semaglutide) injection 7.2 mg is available now nationwide, delivering the highest weight loss of any Wegovy injection to date
Minor soreness at the injection site may occur but usually subsides within a day
FDA-Approved Oral Options: Rybelsus is an FDA-approved oral semaglutide tablet approved for type 2 diabetes
Affordable & Insurance-Free Simple, transparent pricing with no hidden costs or membership fees
